Tag: PHA MTC ENV HEA BIO

Samsung Biologics reports second quarter 2025 financial results

Recorded Q2'25 consolidated revenue of KRW 1,289.9 billionRecorded Q2'25 consolidated operating profit of KRW 475.6 billionSolid momentum sustained through capacity ramp-up and stable project...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsPHA MTC ENV HEA BIO

A New Chapter of Bold Leadership and Unstoppable Growth

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action – Hagens Berman

Cboe Plans to Cease Japanese Equities Operations

Tag: PHA MTC ENV HEA BIO

Samsung Biologics reports second quarter 2025 financial results

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us